Journal Article

Preventive effects of betamethasone valerate ointment for radiation-induced severe oral mucositis in patients with oral or oropharyngeal cancer: protocol for a multicentre, phase II, randomised controlled trial (Bet-ROM study)

Nakahara, Hirokazu, Funahara, Madoka, Kawashita, Yumiko, Yamamura, Yoshiko, Murata, Maho, Otsuru, Mitsunobu, Saito, Toshiyuki, Umeda, Masahiro, Yoshimatsu, Masako, Soutome, Sakiko, Kojima, Yuka, Shibuya, Yasuyuki, Hasegawa, Takumi, Yamada, Shin-ichi

2022

Overview

IntroductionThis is a randomised, multi-centre, open-label, phase II study to evaluate the efficacy of betamethasone valerate ointment on radiation-induced oral mucositis in patients with head and neck cancer undergoing concomitant radiotherapy with cisplatin or cetuximab.Methods and analysisThe trial will take place at seven hospitals in Japan. Patients will be randomised (1:1) into betamethasone and control groups after the occurrence of grade 1 oral mucositis. In the betamethasone group, patients will use betamethasone valerate ointment five times a day, in addition to usual oral hygiene guidance. The primary endpoint is the incidence and onset time of grade 3 oral mucositis. The secondary endpoints are the incidence and onset time of grade 2 oral mucositis, incidence and onset time of oral candidiasis, completion of radiation therapy and adverse events. Target accrual is 102 patients with a two-sided type I error rate of 5% and 80% power to detect an 80% risk reduction in the incidence of grade 3 oral mucositis.Ethics and disseminationThis study was approved by the Clinical Research Review Board of Nagasaki University (No. CRB20-009). All participants will be required to provide written informed consent. Findings will be disseminated through scientific and professional conferences and peer-reviewed journal publication. The datasets generated during the study will be available from the corresponding author on reasonable request.Trial registration numberjRCTs071200013.

• Publisher: British Medical Journal Publishing Group,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Bacteria / Betamethasone Valerate - therapeutic use / cancer pain / Cancer therapies / Chemotherapy / Clinical Trials, Phase II as Topic / Cytokines / Data collection / Dentists / Dermatitis / Head & neck cancer / head & neck tumours / Head and Neck Neoplasms - complications / Head and Neck Neoplasms - radiotherapy / Humans / Monoclonal antibodies / Mucositis / Multicenter Studies as Topic / Narcotics / Ointments - therapeutic use / Oncology / Oral hygiene / oral medicine / Oropharyngeal Neoplasms - radiotherapy / Pain / Patients / Prevention / Radiation / Radiation Injuries - etiology / Radiation Injuries - prevention & control / Randomized Controlled Trials as Topic / Registration / Steroids / Stomatitis - drug therapy / Stomatitis - etiology / Stomatitis - prevention & control / Targeted cancer therapy / Throat cancer